Table 3.
Clinical outcomes of COVID-19 patients.
| Variable | N | Hospitalization time (days) | Percentiles | P |
|---|---|---|---|---|
| In total | 473 | 43.0 | – | |
| Gender | 0.323 | |||
| Male | 246 | 17.0 | (12.0, 21.0) | |
| Female | 227 | 16.0 | (11.0, 20.0) | |
| Age | 0.030 | |||
| <42 | 223 | 16.0 | (11.0 ,20.0) | |
| ≥42 | 250 | 17.0 | (12.0, 21.0) | |
| Patient type | 0.196 | |||
| Local cases | 248 | 16.0 | (11.0, 20.0) | |
| Imported cases | 225 | 17.0 | (12.0, 21.0) | |
| Exposure history | 0.303 | |||
| Living or traveling in Hubei | 194 | 17.0 | (12.0, 21.0) | |
| Contact with confirmed patients | 244 | 16.0 | (11.0, 21.0) | |
| Without contact history | 35 | 16.0 | (11.0, 20.0) | |
| Symptom | 0.091 | |||
| Fever | 255 | 17.0 | (13.0, 21.0) | |
| Diarrhea | 13 | 14.0 | (10.75, 21.5) | |
| Other symptom | 123 | 16.0 | (12.0, 20.0) | |
| Without symptom | 82 | 14.0 | (10.75, 20.0) | |
| Severity status | <0.001 | |||
| General | 429 | 16.0 | (11.5, 20.0) | |
| Severe | 26 | 20.5 | (14.75, 26.0) | |
| Critical | 18 | 23.5 | (16.25, 32.25) |